These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. Fananapazir L; McAreavey D J Am Coll Cardiol; 1998 Feb; 31(2):259-64. PubMed ID: 9462564 [No Abstract] [Full Text] [Related]
4. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. Lewis JF; Maron BJ J Am Coll Cardiol; 1989 Jan; 13(1):36-45. PubMed ID: 2909578 [TBL] [Abstract][Full Text] [Related]
6. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography. Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555 [TBL] [Abstract][Full Text] [Related]
7. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. Hecht GM; Klues HG; Roberts WC; Maron BJ J Am Coll Cardiol; 1993 Aug; 22(2):489-97. PubMed ID: 8335819 [TBL] [Abstract][Full Text] [Related]
8. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Slade AK; Camm AJ Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163 [TBL] [Abstract][Full Text] [Related]
9. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy. Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346 [TBL] [Abstract][Full Text] [Related]
10. Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death. Yetman AT; McCrindle BW; MacDonald C; Freedom RM; Gow R N Engl J Med; 1998 Oct; 339(17):1201-9. PubMed ID: 9780340 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815 [TBL] [Abstract][Full Text] [Related]
13. Effect of amiodarone-induced hyperthyroidism on left ventricular outflow obstruction after septal myectomy for hypertrophic cardiomyopathy. Pokorney SD; Stone NJ; Passman R; Oyer D; Rigolin VH; Bonow RO Am J Cardiol; 2010 Dec; 106(11):1670-2. PubMed ID: 21094372 [TBL] [Abstract][Full Text] [Related]
14. Systolic anterior motion of the posterior leaflet in hypertrophic cardiomyopathy. Anderson M; Wayangankar S; Sivaram CA Echocardiography; 2014 Apr; 31(4):E128-9. PubMed ID: 24804606 [No Abstract] [Full Text] [Related]
15. Left ventricular outflow tract obstruction in the presence of asymmetric septal hypertrophy and accessory mitral valve tissue treated with alcohol septal ablation. Kim MS; Klein AJ; Groves BM; Quaife RA; Salcedo EE Eur J Echocardiogr; 2008 Sep; 9(5):720-4. PubMed ID: 18490281 [TBL] [Abstract][Full Text] [Related]
16. The mitral valve in hypertrophic cardiomyopathy: it's a long story. Woo A; Jedrzkiewicz S Circulation; 2011 Jul; 124(1):9-12. PubMed ID: 21730319 [No Abstract] [Full Text] [Related]
17. [On the work by S. Reith and H. G. Klues "Therapy and risk-stratification in hypertrophic cardiomyopathy", Z Kardiol 92: 283-293 (2003)]. Schwab J; Bareiter T; Bär I; Gottwik M Z Kardiol; 2003 Sep; 92(9):763. PubMed ID: 14508595 [No Abstract] [Full Text] [Related]
18. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study. Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680 [TBL] [Abstract][Full Text] [Related]
19. Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: an in vitro pulsatile flow study. Lefebvre XP; He S; Levine RA; Yoganathan AP J Heart Valve Dis; 1995 Jul; 4(4):422-38. PubMed ID: 7582155 [TBL] [Abstract][Full Text] [Related]
20. Intracoronary myocardial contrast echocardiography in a patient with drug refractory hypertrophic obstructive cardiomyopathy revealing extensive myocardium at risk for infarction with alcohol septal ablation. Monakier D; Horlick E; Ross J; Woo A; Rakowski H; Schwartz L; Riley MP; Carver JR; Aggarwal K; James EA; Aziz S; Ramsdale DR J Invasive Cardiol; 2004 Sep; 16(9):482-4. PubMed ID: 15353829 [No Abstract] [Full Text] [Related] [Next] [New Search]